$25.84
-0.04 (-0.15%)
Performance
1D
—
1W
—
1M
—
3M
+11.09%
6M
+11.72%
1Y
+278.89%
YTD
-12.35%
Open$25.50
Previous Close$25.88
Day High$27.18
Day Low$25.50
52W High$55.65
52W Low$6.34
Volume—
Avg Volume27.5K
Market Cap3.72B
P/E Ratio365.04
EPS$0.23
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.64
Below
SMA 200
$30.05
Below
RSI (14)
49.5
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.53M | 39.85M | 1.84B |
| Net Income | 21.13M | 26.55M | -354,337,532 |
| Profit Margin | 74.1% | 70.4% | -19.2% |
| EBITDA | 19.04M | 25.26M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | -28.4% | -28.4% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |